Literature DB >> 26756113

Histologic and Molecular Profile of Pediatric Insulinomas: Evidence of a Paternal Parent-of-Origin Effect.

Tricia R Bhatti1, Karthik Ganapathy1, Alison R Huppmann1, Laura Conlin1, Kara E Boodhansingh1, Courtney MacMullen1, Susan Becker1, Linda M Ernst1, N Scott Adzick1, Eduardo D Ruchelli1, Arupa Ganguly1, Charles A Stanley1.   

Abstract

CONTEXT: Acquired insulinomas are rare causes of hyperinsulinemic hypoglycemia in children and are much less common than focal lesions of congenital hyperinsulinism. The latter are known to be associated with isodisomy for paternally transmitted ATP-sensitive potassium channel mutations on 11p15; however, the molecular basis for pediatric insulinomas is not well characterized.
OBJECTIVE: The purpose of this study was to characterize the histopathological and molecular defects in a large group of 12 pediatric insulinomas seen at The Children's Hospital of Philadelphia.
RESULTS: Twelve children with insulinomas were seen between 1971 and 2013, compared to 201 cases with focal congenital hyperinsulinism seen between 1997 and 2014. The age of insulinoma patients ranged from 4-16 years at the time of surgery. Features of MEN1 syndrome were present in five of the 12, including four cases with heterozygous mutations of MEN1 on 11q. Immunohistochemical analysis revealed nuclear loss of p57 staining consistent with loss of the maternal 11p15 allele in 11 of the 12 insulinomas, including all five MEN1-associated tumors. Imbalance of the paternal 11p allele was confirmed by single nucleotide polymorphism genotyping and methylation assays of the 11p imprinting control loci in four of five MEN1-associated tumors and six of seven sporadic insulinomas. In addition, single nucleotide polymorphism genotyping revealed extensive tumor aneuploidy beyond chromosome 11.
CONCLUSIONS: These data indicate that MEN1 mutations are more common in insulinomas in children than in adults. Aneuploidy of chromosome 11 and other chromosomes is common in both MEN1 and non-MEN1 insulinomas. The novel observation of a paternal parent-of-origin effect in all MEN1 and most non-MEN1 tumors suggests a critical role for imprinted growth-regulatory genes in the 11p region in the genesis of β-cell endocrine tumors in children.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26756113      PMCID: PMC4803165          DOI: 10.1210/jc.2015-2914

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  31 in total

1.  Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy.

Authors:  P de Lonlay; J C Fournet; J Rahier; M S Gross-Morand; F Poggi-Travert; V Foussier; J P Bonnefont; M C Brusset; F Brunelle; J J Robert; C Nihoul-Fékété; J M Saudubray; C Junien
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization.

Authors:  E J Speel; J Richter; H Moch; C Egenter; P Saremaslani; K Rütimann; J Zhao; A Barghorn; J Roth; P U Heitz; P Komminoth
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Allele-specific methylated multiplex real-time quantitative PCR (ASMM RTQ-PCR), a powerful method for diagnosing loss of imprinting of the 11p15 region in Russell Silver and Beckwith Wiedemann syndromes.

Authors:  Salah Azzi; Virginie Steunou; Alexandra Rousseau; Sylvie Rossignol; Nathalie Thibaud; Fabienne Danton; Marilyne Le Jule; Christine Gicquel; Yves Le Bouc; Irène Netchine
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

4.  Familial pancreatic exocrine dysfunction with pancreatic calcification.

Authors:  T P Mann; J Rubin
Journal:  Proc R Soc Med       Date:  1969-04

5.  A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications.

Authors:  A Wild; P Langer; A Ramaswamy; B Chaloupka; D K Bartsch
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

Review 6.  Molecular genetics of multiple endocrine neoplasia types 1 and 2.

Authors:  Stephen J Marx
Journal:  Nat Rev Cancer       Date:  2005-05       Impact factor: 60.716

7.  Chromosomal alterations in human pancreatic endocrine tumors.

Authors:  E Stumpf; Y Aalto; A Höög; M Kjellman; T Otonkoski; S Knuutila; L C Andersson
Journal:  Genes Chromosomes Cancer       Date:  2000-09       Impact factor: 5.006

8.  Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis.

Authors:  Laura K Conlin; Brian D Thiel; Carsten G Bonnemann; Livija Medne; Linda M Ernst; Elaine H Zackai; Matthew A Deardorff; Ian D Krantz; Hakon Hakonarson; Nancy B Spinner
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

9.  Cytogenetics of multiple endocrine neoplasia syndrome. II. Chromosome abnormalities in an insulinoma and a glucagonoma from two subjects with MEN1.

Authors:  S Scappaticci; M L Brandi; E Capra; M Cortinovis; P Maraschio; M Fraccaro
Journal:  Cancer Genet Cytogenet       Date:  1992-10-01

10.  Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases.

Authors:  J Poncin; R Abs; B Velkeniers; M Bonduelle; M Abramowicz; J J Legros; A Verloes; M Meurisse; L Van Gaal; C Verellen; L Koulischer; A Beckers
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

View more
  8 in total

Review 1.  Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders.

Authors:  Charles A Stanley
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

2.  Surgical treatment of congenital hyperinsulinism: Results from 500 pancreatectomies in neonates and children.

Authors:  N Scott Adzick; Diva D De Leon; Lisa J States; Katherine Lord; Tricia R Bhatti; Susan A Becker; Charles A Stanley
Journal:  J Pediatr Surg       Date:  2018-10-05       Impact factor: 2.545

3.  Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas.

Authors:  Wenzel M Hackeng; Willemien Schelhaas; Folkert H M Morsink; Charlotte M Heidsma; Susanne van Eeden; Gerlof D Valk; Menno R Vriens; Christopher M Heaphy; Els J M Nieveen van Dijkum; G Johan A Offerhaus; Koen M A Dreijerink; Lodewijk A A Brosens
Journal:  Endocr Pathol       Date:  2020-06       Impact factor: 3.943

Review 4.  Robotic enucleation for pediatric insulinoma with MEN1 syndrome: a case report and literature review.

Authors:  Mei Liang; Jialin Jiang; Hongmei Dai; Xiafei Hong; Xianlin Han; Lin Cong; Anli Tong; Fang Li; Yaping Luo; Weinan Liu; Liangrui Zhou; Wenyu Di; Wenming Wu; Yupei Zhao
Journal:  BMC Surg       Date:  2018-06-19       Impact factor: 2.102

5.  Aberrant methylation underlies insulin gene expression in human insulinoma.

Authors:  Esra Karakose; Huan Wang; William Inabnet; Rajesh V Thakker; Steven Libutti; Gustavo Fernandez-Ranvier; Hyunsuk Suh; Mark Stevenson; Yayoi Kinoshita; Michael Donovan; Yevgeniy Antipin; Yan Li; Xiaoxiao Liu; Fulai Jin; Peng Wang; Andrew Uzilov; Carmen Argmann; Eric E Schadt; Andrew F Stewart; Donald K Scott; Luca Lambertini
Journal:  Nat Commun       Date:  2020-10-15       Impact factor: 14.919

6.  Insulinoma masquerading as a loss of consciousness in a teenage girl: case report and literature review.

Authors:  Meghana Gudala; Mahmuda Ahmed; Rushika Conroy; Ksenia Tonyushkina
Journal:  Int J Pediatr Endocrinol       Date:  2017-10-17

7.  Uncovering the heterogeneous genetic variations in two insulin-expressing tumors in a patient with MEN1.

Authors:  Zai Wang; Liguo Liu; Jie Luo; Jing Guo; Min Zhai; Wenjian Zhang; Zhiying Yang
Journal:  Oncol Lett       Date:  2018-03-06       Impact factor: 2.967

8.  Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas.

Authors:  Huan Wang; Aaron Bender; Peng Wang; Esra Karakose; William B Inabnet; Steven K Libutti; Andrew Arnold; Luca Lambertini; Micheal Stang; Herbert Chen; Yumi Kasai; Milind Mahajan; Yayoi Kinoshita; Gustavo Fernandez-Ranvier; Thomas C Becker; Karen K Takane; Laura A Walker; Shira Saul; Rong Chen; Donald K Scott; Jorge Ferrer; Yevgeniy Antipin; Michael Donovan; Andrew V Uzilov; Boris Reva; Eric E Schadt; Bojan Losic; Carmen Argmann; Andrew F Stewart
Journal:  Nat Commun       Date:  2017-10-03       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.